F, C., J, S., J, W., P, C., & Y, H. (2018, May). Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: Diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors. Cancer Management and Research.
Chicago Style (17th ed.) CitationF, Chen, Shen J, Wang J, Cai P, and Huang Y. "Clinical Analysis of Four Serum Tumor Markers in 458 Patients with Ovarian Tumors: Diagnostic Value of the Combined Use of HE4, CA125, CA19-9, and CEA in Ovarian Tumors." Cancer Management and Research May. 2018.
MLA引文F, Chen, et al. "Clinical Analysis of Four Serum Tumor Markers in 458 Patients with Ovarian Tumors: Diagnostic Value of the Combined Use of HE4, CA125, CA19-9, and CEA in Ovarian Tumors." Cancer Management and Research, May. 2018.